[The use of immunoglobulins and monoclonal antibodies against COVID-19].

Autor: Popadyuk EE; 48 Central Research Institute of the Ministry of Defense of the Russian Federation., Sizikova TE; 48 Central Research Institute of the Ministry of Defense of the Russian Federation., Khmelev AL; 48 Central Research Institute of the Ministry of Defense of the Russian Federation., Timofeev MA; Directorate of the Chief of the Radiation, Chemical and Biological Protection Troops of the Armed Forces of the Russian Federation., Lebedev VN; 48 Central Research Institute of the Ministry of Defense of the Russian Federation., Borisevich SV; 48 Central Research Institute of the Ministry of Defense of the Russian Federation.

Publikováno v: Voprosy virusologii [Vopr Virusol] 2024 May 06; Vol. 69 (2), pp. 119-126. Date of Electronic Publication: 2024 May 06.